These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33789055)

  • 1. High-Throughput Screening for Colloidal Stability of Peptide Formulations Using Dynamic and Static Light Scattering.
    Dauer K; Kamm W; Wagner KG; Pfeiffer-Marek S
    Mol Pharm; 2021 May; 18(5):1939-1955. PubMed ID: 33789055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulations That Suppress Aggregation During Long-Term Storage of a Bispecific Antibody are Characterized by High Refoldability and Colloidal Stability.
    Svilenov HL; Winter G
    J Pharm Sci; 2020 Jun; 109(6):2048-2058. PubMed ID: 32194093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations.
    He F; Woods CE; Becker GW; Narhi LO; Razinkov VI
    J Pharm Sci; 2011 Dec; 100(12):5126-41. PubMed ID: 21789772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability.
    Goldberg DS; Bishop SM; Shah AU; Sathish HA
    J Pharm Sci; 2011 Apr; 100(4):1306-15. PubMed ID: 20960568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous High-Throughput Conformational and Colloidal Stability Screening Using a Fluorescent Molecular Rotor Dye, 4-(4-(Dimethylamino)styryl)-N-Methylpyridinium Iodide (DASPMI).
    Wong JJ; Wright SK; Ghozalli I; Mehra R; Furuya K; Katayama DS
    J Biomol Screen; 2016 Sep; 21(8):842-50. PubMed ID: 27138878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Glycosylation on Protein-Protein Self-Interactions of Monoclonal Antibodies.
    Palakollu V; Motabar L; Roberts CJ
    Mol Pharm; 2024 Mar; 21(3):1414-1423. PubMed ID: 38386020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Point Mutations on the Biophysical Properties of an Antimicrobial Peptide: Development of a Screening Protocol for Peptide Stability Screening.
    Pohl C; Zalar M; Bialy IE; Indrakumar S; Peters GHJ; Friess W; Golovanov AP; Streicher WW; Noergaard A; Harris P
    Mol Pharm; 2020 Sep; 17(9):3298-3313. PubMed ID: 32609526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development.
    Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS
    J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
    Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
    J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Nature of High-Throughput Assays in ADC Formulation Screening.
    Mills BJ; Godamudunage MP; Ren S; Laha M
    J Pharm Sci; 2023 Jul; 112(7):1821-1831. PubMed ID: 37037342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Protein Aggregation in High Concentration Protein Solutions Utilizing Protein-Protein Interactions Determined by Low Volume Static Light Scattering.
    Hofmann M; Winzer M; Weber C; Gieseler H
    J Pharm Sci; 2016 Jun; 105(6):1819-1828. PubMed ID: 27157445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Buffers on Colloidal Property and Aggregation Propensities of a Bispecific Antibody.
    Majumder S; Wang W; Alphonse Ignatius A
    J Pharm Sci; 2019 Mar; 108(3):1139-1147. PubMed ID: 30391414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of colloidal stability of high concentration protein formulations.
    Garidel P; Blume A; Wagner M
    Pharm Dev Technol; 2015 May; 20(3):367-74. PubMed ID: 24392929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.
    McClure SM; Ahl PL; Blue JT
    Pharm Res; 2018 Mar; 35(4):81. PubMed ID: 29508082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay.
    Meza NP; Hardy CA; Morin KH; Huang C; Raghava S; Song J; Zhang J; Wang Y
    Mol Pharm; 2023 Nov; 20(11):5842-5855. PubMed ID: 37867303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching pH values for antibody stabilization and crystallization suggest rationale for accelerated development of biotherapeutic drugs.
    Sjuts H; Schreuder H; Engel CK; Bussemer T; Gokarn Y
    Drug Dev Res; 2020 May; 81(3):329-337. PubMed ID: 31758731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gauging colloidal and thermal stability in human IgG1-sugar solutions through diffusivity measurements.
    Rubin J; Sharma A; Linden L; Bommarius AS; Behrens SH
    J Phys Chem B; 2014 Mar; 118(11):2803-9. PubMed ID: 24555903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide Optimization at the Drug Discovery-Development Interface: Tailoring of Physicochemical Properties Toward Specific Formulation Requirements.
    Evers A; Pfeiffer-Marek S; Bossart M; Heubel C; Stock U; Tiwari G; Gebauer B; Elshorst B; Pfenninger A; Lukasczyk U; Hessler G; Kamm W; Wagner M
    J Pharm Sci; 2019 Apr; 108(4):1404-1414. PubMed ID: 30528197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.